| Model Number |
8888145040P |
| Medical Device Problem Code |
Break (1069)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
09/19/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, a fluid leakage was observed at the subcutaneous tunnel (exit site) of a hemodialysis catheter, requiring its removal.No breach was found on the removed catheter.Fortunately, the arteriovenous fistula was just operational, so it was urgently replaced for further care (catheter reimplantation).No patient health incidents.The action was taken in the care setting for patient management.Device change with explantation of the offending device.The catheter was not repaired.There was no luer adapter issue.There was no reported patient injury.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: b5, g3 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, a fluid leakage was observed at the subcutaneous tunnel (exit site) of a hemodialysis catheter, requiring the entire catheter to be removed.No breach was found on the removed catheter.Nothing unusual was observed about the device prior to use.The catheter was not repaired.There was no luer adapter issue.Flushing was done, and nothing particular was observed.There was no excessive force applied to the device.Apart from the reported issue, there were no other visible defects or damages on the product at the time of the incident.The catheter was in place for approximately 7 weeks.The dialysis catheter had to be ablated, but fortunately, the patient had an arteriovenous fistula (avf) that had just become operational and was urgently used/pricked to continue dialysis sessions.It was urgently replaced for further care (catheter reimplantation) as a corrective action.No patient health incidents.The action was taken in the care setting for patient management.Device change with explantation of the offending device.The procedure was completed after the corrective action.There was no medical intervention or treatment required as a result of the incident.There was a small amount of blood loss, and there was no blood transfusion required.There was no reported patient injury.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: b5, g3 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
According to the reporter, a fluid leakage was observed at the subcutaneous tunnel (exit site) of a hemodialysis catheter, requiring the entire catheter to be removed.No breach was found on the removed catheter.Nothing unusual was observed about the device prior to use.The catheter was not repaired.There was no luer adapter issue.Flushing was done, and nothing particular was observed.There was no excessive force applied to the device.Apart from the reported issue, there were no other visible defects or damages on the product at the time of the incident.The catheter was in place for approximately 7 weeks.Fortunately, the arteriovenous fistula was just operational, so it was urgently replaced for further care (catheter reimplantation) as a corrective action.No patient health incidents.The action was taken in the care setting for patient management.Device change with explantation of the offending device.The procedure was completed after the corrective action.There was no medical intervention or treatment required as a result of the incident.There was a small amount of blood loss, and there was no blood transfusion required.There was no reported patient injury.
|
| |
|
Additional Manufacturer Narrative
|
|
Correction: g3 medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: d9, g3, h3, h6 h3 evaluation summary: mozarc medical conducted an investigation based upon all information received.The device was available for evaluation.The evaluation found no potentially contributing factors, and the sample met all related specifications.The manufacturing records for each device are thoroughly reviewed prior to release to ensure that it meets all mozarc medical quality specifications.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|